Severe Mitral Insufficiency Following Mitral Valvotomy

Original title: Acute Severe Mitral Regurgitation Following Balloon Mitral Valvulotomy: Echocardiographic Feature, Operative Finfing and Outcome in 50 Surgical Cases. Reference: Manjunath C. Nanjappa, et al. Catherization and Cardiovascular Intervention 81:603-608 (2013)

Severe Mitral Insufficiency Following Mitral Valvotomy (VPM) is a major complication; though not frequent, (0.9%-2%) it is life threatening and requires resolution through valve replacement.

The aim of this series was to analyze the evolution of patients with acute severe mitral insufficiency following VPM. 3855 patients undergoing VPM were analyzed, 50 patients (1.3%) presented ASMR after procedure and where referred to surgery. Wilkins score was ≤8 in 23 of those 50 patients. The most frequent signs of ASMR were hypotension and hypoxia followed by orthopnea and acute pulmonary edema.

The most frequent cause of severe MR was posterior mitral leaflet tear (36 patients), it was also observe a paracommisural tear with annular involvement (7 patients), posterior mitral leaflet tear (5 patients) and chordal tear (2ptes). The time from end of procedure to replacement surgery was between 3 and 96 hrs, and 6 patients died in this period (12%).

Patients were analyzed according to the moment of surgery and were divided in 2 groups: 24 hrs (11 patients). Both groups shared similar characteristics, mortality being significantly higher in the second group (1/39 vs 5/11, p<0.001).

Conclusion: 

Hypotension and hypoxia were the most common symptoms of Severe Mitral Insufficiency Following Mitral Valvotomy and posterior mitral leaflet tear was the most frequent cause. In this scenario, early valve replacement is most recommended.

Editorial comment: 

Mitral Valvotomy is a complex procedure that presents a low complications rate but these can be severe. Clinical, hemodynamic evaluation, with eco-Doppler is essential seeing that they not only help evaluate results, they also help diagnose complications and make the correct and timely decisions. 

Courtesy of Dr. Carlos Fava.
Interventional Cardiologist.
Favaloro Foundation. Argentina.

 

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

Coronary artery disease progression after transcatheter aortic valve replacement: quantitative coronary angiography and Quantitative Flow Ratio analysis

The coexistence of coronary artery disease and severe aortic stenosis is common among patients undergoing transcatheter aortic valve replacement (TAVR). However, the impact of...

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...